ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis.

Duveken B Y Fontein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.